WuXi PharmaTech Co., Ltd. Statement On Recent News Report

SHANGHAI, Jan. 5, 2015 /PRNewswire/ -- WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does not relate to WuXi PharmaTech.

Ron Aldridge 
Director of Investor Relations 
WuXi PharmaTech 
+1 201-585-2048 
+1 952-594-0148 (U.S.)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wuxi-pharmatech-statement-on-recent-news-report-300015312.html

SOURCE WuXi PharmaTech

Help employers find you! Check out all the jobs and post your resume.

Back to news